Fujian Cosunter Pharmaceutical Co Ltd Total Liabilities
Fujian Cosunter Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Fujian Cosunter Pharmaceutical Co Ltd (300436) has total liabilities worth CN¥1.07 Billion CNY (≈ $156.03 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See 300436 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Fujian Cosunter Pharmaceutical Co Ltd (2011–2025)
Total liabilities of Fujian Cosunter Pharmaceutical Co Ltd from 2011 to 2025. This chart illustrates how Fujian Cosunter Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Fujian Cosunter Pharmaceutical Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Fujian Cosunter Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Fujian Cosunter Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Compañía Cervecerías Unidas S.A
F:CVU
|
Germany | €1.91 Trillion |
|
Grupo Lamosa S.A.B. de C.V
MX:LAMOSA
|
Mexico | MX$27.10 Billion |
|
HBX Group International plc
MC:HBX
|
Spain | €2.63 Billion |
|
Qingdao Sentury Tire Co Ltd
SHE:002984
|
China | CN¥4.60 Billion |
|
Investec Ltd
JSE:INL
|
South Africa | ZAC645.87 Billion |
|
Genting Malaysia Bhd
KLSE:4715
|
Malaysia | RM19.44 Billion |
|
A10 Network
NYSE:ATEN
|
USA | $439.71 Million |
|
Xinjiang Joinworld Co Ltd
SHG:600888
|
China | CN¥7.50 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Fujian Cosunter Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 300436 total asset value.
Liquidity & Leverage Metrics
Fujian Cosunter Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Fujian Cosunter Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 5.09 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.80 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fujian Cosunter Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fujian Cosunter Pharmaceutical Co Ltd (2011–2025)
The table below shows the annual total liabilities of Fujian Cosunter Pharmaceutical Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.05 Billion ≈ $154.26 Million |
+1.17% |
| 2024-12-31 | CN¥1.04 Billion ≈ $152.48 Million |
-0.31% |
| 2023-12-31 | CN¥1.05 Billion ≈ $152.95 Million |
+93.84% |
| 2022-12-31 | CN¥539.22 Million ≈ $78.91 Million |
+35.85% |
| 2021-12-31 | CN¥396.92 Million ≈ $58.08 Million |
-6.41% |
| 2020-12-31 | CN¥424.10 Million ≈ $62.06 Million |
+31.50% |
| 2019-12-31 | CN¥322.51 Million ≈ $47.19 Million |
+10.32% |
| 2018-12-31 | CN¥292.33 Million ≈ $42.78 Million |
+58.51% |
| 2017-12-31 | CN¥184.42 Million ≈ $26.99 Million |
+24.35% |
| 2016-12-31 | CN¥148.30 Million ≈ $21.70 Million |
+81.96% |
| 2015-12-31 | CN¥81.50 Million ≈ $11.93 Million |
+21.21% |
| 2014-12-31 | CN¥67.24 Million ≈ $9.84 Million |
+23.56% |
| 2013-12-31 | CN¥54.42 Million ≈ $7.96 Million |
+33.33% |
| 2012-12-31 | CN¥40.82 Million ≈ $5.97 Million |
-6.93% |
| 2011-12-31 | CN¥43.86 Million ≈ $6.42 Million |
-- |
About Fujian Cosunter Pharmaceutical Co Ltd
Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. The company offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men's health, and other fields. It also provides technical services such as drug development, including the deve… Read more